Adaptimmune Therapeutics PLCNASDAQ:ADAP
- LAST PRICE1.0100
- TODAY'S CHANGE (%)-0.0300 (-2.8846%)
- Bid / Lots1.0000/ 232
- Ask / Lots1.0200/ 18
- Open / Previous Close1.0300 / 1.0400
- Day Range
- 52 Week Range
- Volume820,469
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ADAP |
|---|---|---|
| 09:32 ET | 26238 | 1.03 |
| 09:34 ET | 1200 | 1.025 |
| 09:36 ET | 5220 | 1.01 |
| 09:38 ET | 1200 | 1.03 |
| 09:39 ET | 550 | 1 |
| 09:41 ET | 1200 | 1 |
| 09:43 ET | 1650 | 1.02 |
| 09:45 ET | 3600 | 1.01 |
| 09:48 ET | 3404 | 1.0104 |
| 09:50 ET | 1200 | 1.02 |
| 09:52 ET | 2300 | 1.01 |
| 09:54 ET | 2462 | 1.02 |
| 09:56 ET | 1500 | 1.015 |
| 09:57 ET | 1000 | 1.02 |
| 09:59 ET | 1400 | 1.02 |
| 10:01 ET | 5300 | 1.01 |
| 10:03 ET | 1838 | 1.02 |
| 10:06 ET | 1911 | 1.015 |
| 10:08 ET | 1700 | 1.015 |
| 10:10 ET | 300 | 1.01 |
| 10:12 ET | 27552 | 1.015 |
| 10:14 ET | 28000 | 1.015 |
| 10:15 ET | 1800 | 1.015 |
| 10:17 ET | 16441 | 1.01 |
| 10:19 ET | 1900 | 1.015 |
| 10:21 ET | 1900 | 1.01 |
| 10:26 ET | 5464 | 1.01 |
| 10:28 ET | 6695 | 1.015 |
| 10:30 ET | 200 | 1.01 |
| 10:32 ET | 6287 | 1.01 |
| 10:33 ET | 2365 | 1.015 |
| 10:35 ET | 1700 | 1.015 |
| 10:37 ET | 100 | 1.01 |
| 10:39 ET | 300 | 1.01 |
| 10:42 ET | 700 | 1.01 |
| 10:44 ET | 77703 | 1.005 |
| 10:46 ET | 500 | 1 |
| 10:48 ET | 200 | 1.005 |
| 10:50 ET | 1500 | 1 |
| 10:51 ET | 24700 | 1 |
| 10:53 ET | 2300 | 1.005 |
| 10:55 ET | 34507 | 1 |
| 10:57 ET | 300 | 1.005 |
| 11:00 ET | 3100 | 1.005 |
| 11:02 ET | 200 | 1.005 |
| 11:04 ET | 1137 | 1.005 |
| 11:06 ET | 5200 | 1.005 |
| 11:08 ET | 12200 | 1 |
| 11:09 ET | 32400 | 1 |
| 11:11 ET | 398 | 1 |
| 11:13 ET | 3300 | 1.005 |
| 11:15 ET | 1322 | 1 |
| 11:18 ET | 800 | 1 |
| 11:20 ET | 1900 | 1.01 |
| 11:22 ET | 379 | 1 |
| 11:24 ET | 100 | 1 |
| 11:26 ET | 1600 | 1 |
| 11:27 ET | 83550 | 1.005 |
| 11:29 ET | 300 | 1.005 |
| 11:31 ET | 2394 | 1.005 |
| 11:33 ET | 500 | 1.005 |
| 11:36 ET | 300 | 1 |
| 11:38 ET | 1600 | 1.005 |
| 11:42 ET | 100 | 1 |
| 11:44 ET | 1100 | 1.005 |
| 11:45 ET | 1600 | 1 |
| 11:47 ET | 15687 | 1.005 |
| 11:49 ET | 12318 | 1.015 |
| 11:51 ET | 200 | 1.01 |
| 11:54 ET | 100 | 1.01 |
| 11:56 ET | 6323 | 1.01 |
| 11:58 ET | 2200 | 1.01 |
| 12:00 ET | 39417 | 1.005 |
| 12:02 ET | 100 | 1.01 |
| 12:09 ET | 520 | 1.0099 |
| 12:12 ET | 800 | 1.005 |
| 12:18 ET | 1400 | 1.0099 |
| 12:20 ET | 390 | 1.0099 |
| 12:21 ET | 400 | 1 |
| 12:23 ET | 1200 | 1 |
| 12:25 ET | 100 | 1 |
| 12:27 ET | 200 | 1.005 |
| 12:30 ET | 600 | 1.005 |
| 12:32 ET | 23056 | 1.005 |
| 12:34 ET | 1395 | 1.005 |
| 12:36 ET | 1700 | 1.005 |
| 12:38 ET | 500 | 1.0098 |
| 12:39 ET | 1400 | 1 |
| 12:41 ET | 10145 | 1 |
| 12:43 ET | 400 | 1 |
| 12:45 ET | 400 | 1.005 |
| 12:48 ET | 1500 | 1.005 |
| 12:50 ET | 11652 | 1.005 |
| 12:57 ET | 3600 | 1.005 |
| 12:59 ET | 200 | 1 |
| 01:01 ET | 700 | 1 |
| 01:03 ET | 1200 | 1.005 |
| 01:06 ET | 2300 | 1.005 |
| 01:08 ET | 500 | 1 |
| 01:10 ET | 300 | 1 |
| 01:12 ET | 400 | 1 |
| 01:14 ET | 3762 | 1.005 |
| 01:15 ET | 19347 | 1.005 |
| 01:17 ET | 1000 | 1.005 |
| 01:19 ET | 400 | 1 |
| 01:21 ET | 3200 | 1.005 |
| 01:24 ET | 300 | 1.005 |
| 01:26 ET | 188 | 1 |
| 01:28 ET | 887 | 1.005 |
| 01:30 ET | 5549 | 1.01 |
| 01:32 ET | 2150 | 1.005 |
| 01:33 ET | 1000 | 1 |
| 01:35 ET | 300 | 1 |
| 01:37 ET | 3695 | 1.005 |
| 01:39 ET | 600 | 1 |
| 01:42 ET | 1700 | 1 |
| 01:44 ET | 700 | 1 |
| 01:46 ET | 705 | 1.005 |
| 01:48 ET | 719 | 1 |
| 01:50 ET | 1800 | 1.005 |
| 01:51 ET | 400 | 1.005 |
| 01:53 ET | 600 | 1 |
| 01:55 ET | 883 | 1 |
| 01:57 ET | 600 | 1 |
| 02:00 ET | 1700 | 1.005 |
| 02:02 ET | 1202 | 1.005 |
| 02:04 ET | 1300 | 1.005 |
| 02:06 ET | 200 | 1 |
| 02:08 ET | 900 | 1.005 |
| 02:09 ET | 100 | 1.005 |
| 02:13 ET | 200 | 1.005 |
| 02:15 ET | 200 | 1 |
| 02:18 ET | 14419 | 1.005 |
| 02:20 ET | 500 | 1.005 |
| 02:22 ET | 298 | 1.003 |
| 02:24 ET | 100 | 1.005 |
| 02:26 ET | 100 | 1.005 |
| 02:27 ET | 100 | 1.005 |
| 02:29 ET | 100 | 1.005 |
| 02:31 ET | 10699 | 1.005 |
| 02:33 ET | 5900 | 1.005 |
| 02:36 ET | 300 | 1.005 |
| 02:38 ET | 100 | 1.005 |
| 02:40 ET | 200 | 1.005 |
| 02:44 ET | 1200 | 1.01 |
| 02:47 ET | 198 | 1 |
| 02:51 ET | 827 | 1.005 |
| 02:54 ET | 124 | 1.0096 |
| 02:56 ET | 200 | 1.0075 |
| 02:58 ET | 300 | 1 |
| 03:00 ET | 200 | 1 |
| 03:02 ET | 2857 | 1.005 |
| 03:05 ET | 100 | 1 |
| 03:07 ET | 300 | 1.005 |
| 03:09 ET | 562 | 1 |
| 03:12 ET | 2400 | 1.005 |
| 03:14 ET | 300 | 1 |
| 03:16 ET | 4530 | 1 |
| 03:18 ET | 100 | 1.005 |
| 03:20 ET | 400 | 1 |
| 03:21 ET | 4800 | 1.005 |
| 03:23 ET | 1300 | 1.0068 |
| 03:25 ET | 616 | 1 |
| 03:27 ET | 5887 | 1.005 |
| 03:30 ET | 2800 | 1.005 |
| 03:32 ET | 500 | 1.005 |
| 03:34 ET | 2086 | 1 |
| 03:36 ET | 9761 | 1.005 |
| 03:38 ET | 300 | 1.005 |
| 03:39 ET | 2600 | 1 |
| 03:41 ET | 500 | 1.005 |
| 03:43 ET | 12595 | 1.005 |
| 03:45 ET | 17233 | 1.01 |
| 03:48 ET | 3050 | 1 |
| 03:50 ET | 700 | 1.005 |
| 03:52 ET | 3567 | 1.01 |
| 03:54 ET | 1773 | 1.01 |
| 03:56 ET | 1946 | 1 |
| 03:57 ET | 6065 | 1.005 |
| 03:59 ET | 15465 | 1.01 |
May 17, 2024
DJ Adaptimmune Therapeutics Is Maintained at Buy by Mizuho, from 7:41AM ET on Friday May 17, 2024 by Dow Jones
7:41AM ET on Friday May 17, 2024 by Dow Jones
May 15, 2024
Adaptimmune Reports Q1 2024 Financial and Business Updates, from 7:32AM ET on Wednesday May 15, 2024 by Dow Jones
7:32AM ET on Wednesday May 15, 2024 by Dow JonesAdaptimmune Secures up to $125 Million Debt Financing with Hercules Capital, from 7:01AM ET on Wednesday May 15, 2024 by Dow Jones
7:01AM ET on Wednesday May 15, 2024 by Dow Jones
May 1, 2024
Adaptimmune to Report Q1 2024 Financial and Business Updates on Wednesday, May 15, 2024, from 12:01PM ET on Wednesday May 01, 2024 by Dow Jones
12:01PM ET on Wednesday May 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Adaptimmune Therapeutics PLC | 265.8M | -1.4x | --- |
MacroGenics Inc | 271.8M | -11.0x | --- |
Innate Pharma SA | 230.9M | -27.4x | --- |
Poseida Therapeutics Inc | 277.3M | -2.4x | --- |
Codexis Inc | 222.3M | -3.4x | --- |
AVITA Medical Inc | 222.7M | -5.0x | --- |
Company Information
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. The Company is focused on providing cell therapies to people with cancer. Its engineered T-cell receptor (TCR) platform enables the engineering of T-cells to target and destroy cancers across multiple solid tumor types. Its cell therapy candidates include TCR T-cells and TruC T-cells. Its product candidates include afamitresgene autoleucel (afami-cel) and Lete-cel. The afamicel is a cell therapy that provides a treatment option for people with synovial sarcoma. The Company is in the process of transitioning lete-cel, which targets the NY-ESO antigen in people with synovial sarcoma and myxoid round cell liposarcoma (MRCLS). Its clinical pipeline includes SURPASS-III Phase II Trial with ADP-A2M4CD8 and SURPASS Phase I Trial with ADP-A2M4CD8. The Company’s most advanced pre-clinical programs are for T-cell therapies directed to the PRAME target (ADP-600) and to CD70 (ADP-520). ADAP-600 is an engineered TCR T-cell.
Contact Information
- Headquarters
- 60 Jubilee Avenue, Milton ParkABINGDON, United Kingdom OX14 4RX
- Phone
- 123-543-0000
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- David Mott
- Chief Executive Officer, Director
- Adrian Rawcliffe
- Chief Financial Officer
- Gavin Wood
- Chief Operating Officer
- William Bertrand
- Chief Scientific Officer
- Joanna Brewer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $265.8M |
|---|---|
Revenue (TTM) | $18.4M |
Shares Outstanding | 255.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.30 |
EPS | $-0.73 |
Book Value | $0.17 |
P/E Ratio | -1.4x |
Price/Sales (TTM) | 14.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -918.45% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
